What does client service mean to us? It means developing custom relationships, sharing our technical expertise, and providing practical solutions delivered by pragmatic IP professionals who are easy to work with. We carefully structure our teams to ensure that we have the right blend of knowledge and experience to meet the unique needs of each client. Regardless of the industry in which you operate, our patent, design and trade mark specialists will quickly understand your business and your IP issues, with the addition of significant value right from the start of the working relationship.
EXPERTISE
"They are a very bright, thoughtful bunch and are easy to work with. Their advice is timely, comprehensive, commercial and very sound."
Client quote, Chambers and PartnersWe are a people business. To deliver exceptional service to our clients, we seek individuals with a combination of talent, commercial awareness, and integrity. Our clients depend on our expertise – but they also appreciate our individual personalities and our collaborative way of working. Within a supportive working environment, we empower our staff to strive for excellence. We recognise that when our employees reach their full potential, our firm also succeeds.
CAREERST 1043/24 aligns with the anticipated outcome of G 1/25, confirming that description amendments are needed to address inconsistencies with amended claims while allowing unclaimed embodiments to remain
From 1 July 2026, Phase II of the EU Design Reform introduces dynamic and animated representations, more design views, amendment options, and significant procedural changes.
Boult is delighted to announce that our charity partner for 2026-2027 is Great Ormond Street Hospital Charity (GOSH Charity).
Boult trade mark partners Emma Pitcher and Dr Catherine Wolfe have been recognised in the WTR’s Global Leaders for Private Practice UK
Boult’s guide to IP rights and exclusivity for pharma and biotech in Europe.
Discover how patent protection plays a fundamental role in incentivising and rewarding research and development in the pharmaceutical and biotechnology sectors.
TRENDING TOPICS
